fast track approval
12/03/2017
/
By Isabelle Z.
Most cancer drugs make it to the market without any proof they’re safe or effective
As if suffering from cancer weren’t bad enough on its own, a new study has found that nearly two-thirds of the cancer drugs that gained authorization from the European Medicines Agency (EMA) from 2009 to 2013 did not offer any clear proof that they would extend or improve patients’ lives. The study, which was carried […]
« Return Home
1 of 1
Popular Articles
COPYRIGHT © 2017 BIG PHARMA NEWS
Privacy Policy